Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study. - Wikidata - wikimedia - TriplyDB

Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study.

Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study.

http://www.wikidata.org/entity/Q37176188

about

Pelvic inflammatory disease increases the risk of a second primary malignancy in patients with cervical cancer treated by surgery alone Gastric metastases from gynaecologic tumors: case reports and review of the literature Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports.The prognostic impact of overall treatment time on disease outcome in uterine cervical cancer patients treated primarily with concomitant chemoradiotherapy: a nationwide Taiwanese cohort study.Triple malignancy in a single patient including a squamous cell carcinoma of the cervix, a colloid adenocarcinoma of the colon and a lung adenocarcinoma: A case report and literature review.

P2860

Q37468196-5662B608-B873-478B-AAEA-797598FA044B Q37583818-69CF5661-CF31-4A14-A720-85B864A1B7A7 Q40290855-DED6EFD4-0F3B-4D55-B3CF-DB235CD1E9F9 Q41104910-DAAA38EE-1877-4C31-9A3F-7945881CA473 Q45809509-AF866196-DAE1-4AC7-B0FA-74F51BA3AED3 Q47145744-DAC36076-D6AB-4A9B-A558-25FED7E4913A

P2860

Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study.

http://www.wikidata.org/entity/Q37176188

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Secondary Primary Malignancy R ...... onwide Population-Based Study.

@en

Secondary Primary Malignancy R ...... onwide Population-Based Study.

@nl

type

label

Secondary Primary Malignancy R ...... onwide Population-Based Study.

@en

Secondary Primary Malignancy R ...... onwide Population-Based Study.

@nl

prefLabel

Secondary Primary Malignancy R ...... onwide Population-Based Study.

@en

Secondary Primary Malignancy R ...... onwide Population-Based Study.

@nl

P1433

Q37176188-397F6D6A-CA23-44C7-9E01-1304565C7B5D

P1476

Q37176188-4716AA6B-D656-4D2D-8260-160916232706

P2093

Q37176188-1230682E-14C7-4E01-8C6D-14427C62C516

Q37176188-20178C55-5301-4D80-8EF0-4F7AB77C771F

Q37176188-47CEF47D-2C4C-4CF0-95B5-0F5D4C8D2068

Q37176188-5395B02F-64E0-43D8-8C08-BFF863D5CC3B

Q37176188-8A309946-3427-46DB-9930-4B54E0CFD9FB

Q37176188-A8FF358D-096F-4356-A1A5-E40028DBDC84

Q37176188-B0FA66F7-2E46-4C5A-9078-4B5732CA5A0D

Q37176188-B8E7D6C9-F952-4C93-9482-BD6F9A610226

P2860

Q37176188-0921324E-028A-40F2-9785-37504B82DAEA

Q37176188-292284C4-191F-4835-B773-9FCA9F4B8778

Q37176188-2D20E92E-9ADB-41AA-822A-9F84063AA543

Q37176188-3785DB05-141D-412A-8F43-A0334EEAB71E

Q37176188-4217FE56-0B44-4636-ACEE-B069A56C349E

Q37176188-45BCFC21-54D5-4BA9-AE22-F7F4C0B80FB7

Q37176188-4A4758FE-E17C-401A-B6F8-E38337526406

Q37176188-59865D99-8114-40FD-970E-18DEFFEF243E

Q37176188-5C038260-B6E2-4DAB-8219-058AED4AC744

Q37176188-5C545E0A-7C5E-4C70-9B80-29D7B05EA74D

P304

Q37176188-A3644745-3525-4F84-846E-99A58F3A9C55

P31

Q37176188-07EC0CFF-DA71-4C57-89EF-BDCA4C217B5D

P356

Q37176188-1182D2C2-813F-4016-98AE-A7E537A6AF1C

P407

Q37176188-97BA7432-D0EE-4AB1-9EB4-602C0AEE885B

P433

Q37176188-A84CE57E-8943-419B-9C2C-00C38E67F455

P478

Q37176188-85299264-9528-4339-B5B1-708A6726DDC0

P50

Q37176188-FC4F5878-A9BA-4E1C-86A0-86D8E1265BE9

P577

Q37176188-E59183B9-CDD3-492E-A31D-00B57A4CFEE0

P698

Q37176188-DAA19358-D068-47B8-A16D-FB4ACE8F85FC

P932

Q37176188-92D2EFCB-6271-40EF-AFB2-150016FF347D

P356

MD.0000000000001803

P1433

P1476

Secondary Primary Malignancy R ...... ionwide Population-Based Study

@en

P2093

Chia-Jen Liu

http://www.w3.org/2001/XMLSchema#string

Chiu-Mei Yeh

http://www.w3.org/2001/XMLSchema#string

Chung-Jen Teng

http://www.w3.org/2001/XMLSchema#string

Leh-Kiong Huon

http://www.w3.org/2001/XMLSchema#string

Muh-Hwa Yang

http://www.w3.org/2001/XMLSchema#string

Tzeng-Ji Chen

http://www.w3.org/2001/XMLSchema#string

Yee Chao

http://www.w3.org/2001/XMLSchema#string

Yi-Ping Hung

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm.

Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers.

Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study.

Is cisplatin a human carcinogen?

Second primary cancer following treatment for cervical cancer.

Cyclophosphamide and cancer: golden anniversary.

Taiwan's new national health insurance program: genesis and experience so far.

Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study.

Cervical cancer survivors at increased risk of subsequent tobacco-related malignancies, United States 1992-2008.

Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study.

P304

e1803

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000001803

http://www.w3.org/2001/XMLSchema#string

P407

P433

43

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26512575

http://www.w3.org/2001/XMLSchema#string

P932

4985389

http://www.w3.org/2001/XMLSchema#string